ZimVie Inc
NASDAQ:ZIMV
ZimVie Inc
Cash Equivalents
ZimVie Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Z
|
ZimVie Inc
NASDAQ:ZIMV
|
Cash Equivalents
$71.5m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Boston Scientific Corp
NYSE:BSX
|
Cash Equivalents
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
76%
|
CAGR 10-Years
28%
|
|
Stryker Corp
NYSE:SYK
|
Cash Equivalents
$2.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash Equivalents
$6.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash Equivalents
$2.2B
|
CAGR 3-Years
39%
|
CAGR 5-Years
29%
|
CAGR 10-Years
11%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Cash Equivalents
$281.7m
|
CAGR 3-Years
70%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is ZimVie Inc's Cash Equivalents?
Cash Equivalents
71.5m
USD
Based on the financial report for Dec 31, 2023, ZimVie Inc's Cash Equivalents amounts to 71.5m USD.
What is ZimVie Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
38%
Over the last year, the Cash Equivalents growth was -20%. The average annual Cash Equivalents growth rates for ZimVie Inc have been 38% over the past three years .